Nanophase Announces New Supply Agreement with BASF


ROMEOVILLE, Ill., June 20 /PRNewswire-FirstCall/ -- Nanophase Technologies (NASDAQ:NANX), a technology leader in nanomaterials and advanced nanoengineered products, announced a new mutually exclusive supply agreement with BASF to supply patent-pending surface engineered nanoparticles for current and future products for BASF's Z-COTE® MAX brand. The new supply agreement is multi-year with automatic renewals and is in addition to the Company's current agreement with BASF for the Z-COTE® brand.

"We are honored to be a designated strategic development partner for BASF and proud of our mutual collaboration on this new line of BASF products," stated Joseph Cross, Nanophase's president and CEO. "BASF and Nanophase collaboratively developed this new nanomaterial technology over two years in extensive surface treatment development and formulation testing resulting in new products and associated pending patents. We are optimistic about positive market acceptance and mutual revenue growth in the future."

Nanophase Technologies Corporation (NASDAQ:NANX), www.nanophase.com, is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2000 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company owns or licenses 18 United States and 43 foreign patents and patent applications. Information about Nanophase may be found in the Company's public filings or on its website.

Source: Nanophase Technologies Corporation

CONTACT: Joseph Cross, President, CEO, +1-630-771-6705; Jess Jankowski, VP, CFO, +1-630-771-6702; Susan Barrett, Investor Relations, +1-630-771-6704, all of Nanophase Technologies Corporation

Web site: www.nanophase.com/

All Topics